In early-onset severe hemolytic disease of the fetus and newborn (HDFN), transplacental transfer of maternal antierythrocyte IgG alloantibodies causes fetal anemia that leads to the use of high-risk ...
What Is Hemolytic Disease of the Fetus and Newborn? Hemolytic disease of the fetus and newborn (HDFN) is a blood disorder that happens when your blood type doesn't match your baby's blood type during ...
Please provide your email address to receive an email when new articles are posted on . Alloimmunization rates were 6.2% for women matched to ABO and Rhesus D and 1.9% for women also matched for c, E ...
Nipocalimab is a fully human, anti-FcRn, aglycosylated IgG1 monoclonal antibody that reduces pathogenic alloantibodies in maternal circulation and blocks the placental transfer of maternal IgG to the ...
Hemolytic disease of the newborn is a type of anemia that begins during pregnancy. It can cause serious illness in a newborn, but it may be diagnosed during prenatal screening and treated to avoid ...
The Food and Drug Administration (FDA) has granted Fast Track designation to nipocalimab (M281) for the prevention of hemolytic disease of the fetus and newborn (HDFN). The Food and Drug ...
DEAR DR. ROACH: My wife is Rh negative, and I am Rh positive. Our baby (fetus) is positive. I am worried about my wife and my baby. Is this dangerous? What can be done? This is her second pregnancy. - ...
CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback